Cargando…
LBSUN154 Baseline Albuminuria May Protect Against Severe Covid-19 In Type 2 Diabetes Patients
BACKGROUND: Diabetes is considered as one of the leading risk factors for severe COVID-19. We aimed to characterize the differences between type 2 diabetic patients after hospitalization in medical departments at our medical center due to COVID-19 or other diseases. Among the patients with COVID-19,...
Autores principales: | Bashkin, Amir, Shehadeh, M, Shbita, L, Namoura, K, Haiek, R, Kuyantseva, E, Boulos, Y, Zur, A, Nodelman, M, Kruzel-Davila, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624580/ http://dx.doi.org/10.1210/jendso/bvac150.580 |
Ejemplares similares
-
Baseline moderate-range albuminuria is associated with protection against severe COVID-19 pneumonia
por: Bashkin, Amir, et al.
Publicado: (2022) -
LBSUN152 The Warburg Effect And Complex Thermomics Inform Phenotypic Expression
por: Fredericks, Robert S
Publicado: (2022) -
LBSUN151 The Impact Of The COVID-19 Pandemic On Diabetes & Weight Management
por: Hashmi, Hiba Z, et al.
Publicado: (2022) -
LBSUN205 Clinical Practice Guidelines With Education Make A Difference
por: Mohieldin, Mohamed Elfatih
Publicado: (2022) -
LBSUN213 An Investigation Into The Effects Of Dapagliflozin On Ketogenesis In Type 1 Diabetes
por: Ghanim, Husam, et al.
Publicado: (2022)